Cyclosporin A is a calcineurin/NFATc1 inhibitor that has been demonstrated as an immunosuppressive agent to prevent bone loss in mouse RA models and to prevent the activation of NFATc117. This evidence concerns the gene NFATC1 and rheumatoid arthritis.